Acide Tranexamique Stragen

Acide Tranexamique Stragen is a pharmaceutical product containing tranexamic acid, used for various medical purposes. This intravenous solution is manufactured by Stragen France and is designed for clinical applications.

Tranexamic acid is commonly used to control bleeding and reduce blood loss during surgeries or medical procedures. It works by stabilizing blood clots and preventing their breakdown. This medication is often utilized in situations where excessive bleeding is a concern, such as during dental extractions or certain types of surgeries.

When administered intravenously, tranexamic acid can help reduce the amount of blood lost during procedures. It is important to follow medical guidance to ensure proper use and to minimize potential side effects. Common effects may include changes in blood clotting and potential interactions with other medications.

Tranexamic acid should be used with caution in individuals with a history of blood clots or clotting disorders. It is essential to inform healthcare providers about any existing medical conditions or medications being taken. Proper storage and handling are crucial to maintain the effectiveness of the solution.

Tranexamic acid may interact with other medications that affect blood clotting, such as anticoagulants. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of tranexamic acid.